• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    BioIVT

    CMC Pharmaceuticals

    Societal CDMO

    LOTTE BIOLOGICS

    Lannett CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    BioIVT

    CMC Pharmaceuticals

    Societal CDMO

    LOTTE BIOLOGICS

    Lannett CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Trends in Pharma Analysis

    A look at how pharma analysis technology continues to evolve to meet market needs

    Trends in Pharma Analysis
    Trends in Pharma Analysis
    Related CONTENT
    • Trust, but Verify
    • Drug Product Safety and Security
    • Too Much of a Good Thing?
    • A Potential “Marriage”
    • The Pandemic’s Become an Insurmountable Opportunity
    Emil W. Ciurczak, DoraMaxx Consulting03.07.17
    There are several trends worth noting in a modern pharmaceutical testing lab: smaller size, different tests, and mirroring production. And, while these may seem dissimilar, they actually go hand-in hand. The combination of the miniaturization of instruments and PAT/QbD has created the atmosphere/demand for more types and faster analyzers. While there has been a demand for smaller, faster instruments for quite a while, hardware and software advances have only caught up recently.

    In the old days of process analytical technology (PAT)—anything more than 10 years ago is old—the paradigm was to capture samples at the point of origin, measure them with the Near-IR, Raman, UV/Visible, or whichever instrument was being used to control the process, then send the samples for lab analysis. To set the record straight, this worked quite nicely for some time since it was much better after the PAT controls were initiated and used routinely. But, it was a tad time-consuming for any new assay or product line and there was always the time lag from sampling to analysis to worry about, especially where volatiles or a continuing reaction was being measured. There could be variations in the amount of volatile(s) and temperature, or in simply capturing the same sample that is scanned by the instrument.

    These potential variances have been somewhat obviated in the past by simply making many measurements on numerous lots of product. While statistically correct, large numbers of samples are both time consuming and tie up equipment and staff. These time and personnel restraints are a large part of the reluctance of both larger and smaller companies resisting adaptation of PAT/QbD (quality by design) programs. However, recent developments in instrumentation may have changed the outlook.

    Smaller and, in some cases, less expensive hardware has come along. In addition to NIR and Raman, which were already being made smaller and smaller, and in less expensive versions of LIBS (LASER-induced breakdown spectroscopy), X-ray fluorescence, and 2-D NMR (nuclear magnetic resonance spectrometry) are now available for PAT and QbD applications. So, not only are on-line measurements becoming easier to calibrate, new parameters are being added to the mix.

    I’ll start with the most obvious: Near-Infrared Spectroscopy. NIR has been in use for raw materials qualification since the mid-1980s. In the beginning, samples were taken in the warehouse and physically brought to the NIR instrument in a lab. At first, the samples were poured into a cup, then inserted into an instrument to be measured. A lot of 225 bags of lactose would take roughly one-half day to sample and analyze, certainly an improvement over the two weeks, using USP or EP wet methods. Very soon after this method, a fiber optic probe allowed samples to be read through the wall of their plastic whirl-packs, speeding the process and lessening the amount of cleaning needed between readings.

    The first foray into in situ measurements was c. 1990, when Bran+Leubbe (formerly Technicon) built an instrument capable of rolling into the warehouse for measurements. Some companies combined vendor validation with statistical sampling to lower the number of containers that needed to be opened and inspected. Nonetheless, the process of RM qualification cannot be sped up much more, even with the introduction of hand-held NIR units (c. 2000). Several companies now sell units and, depending on what is needed by the plant, the materials are measured from simple ID to parameters, such as particle size, moisture, and crystallinity—both percent crystallinity and polymorphic forms.

    It is not surprising that the first in-line technology was NIRS. Developed at Pfizer (by Zeiss) for following blend uniformity, it was the first of several, but still relatively large in size and definitely not easily portable. That was up to Brimrose to make. Their AOTF (accusto-optic tunable filter) instrument was used in blending control and the spectrometer itself could be removed from the mixer cover and used as a hand-held unit. Others have followed.

    The next technique to go mobile was Raman. This technique has a number of advantages over NIR, one of which is that the resultant spectra are more classic in that it resembles infrared. The plethora of distinct, reproducible peaks less affected by physical parameters gives easily identifiable spectra for rapid RMID (raw material ID). And, like MIR, unknowns are more easily identified than the less clean NIR spectra, mostly overlapping and broad peaks.

    Somewhat less well known is LIBS (LASER-induced breakdown spectroscopy). It is simply emission spectroscopy (ES) of solid/semi-sold samples. In classic ES, the sample is first dissolved in a solution (mostly acidic), then aspirated into a plume of (argon) plasma, vaporized, and the atoms reduced to plasma (see Figure 1). As the nuclei and electrons re-unite, they release light, allowing the analyst to quickly determine the elements present and in what concentration. Early, and current, instruments were the size of armoires and needed extensive ventilation for the plumes of chemicals released by the LASER burns.

    In fact, early editions of LIBS were exclusively used for metal atoms—iron, titanium, and magnesium. The iron and titanium are often found in coatings and magnesium in the tablet core—Mg Stearate is one of the most popular lubricants. By pulsing the LASER, a small channel is formed, with each pulse vaporizing materials deeper and deeper into the dosage form. The resultant spectra gleaned from a pattern or spots, allows analysts/formulators/production managers to ascertain 1) the distribution of lubricant within a tablet, and 2) the distribution (uniformity) of Fe and Ti in the coating (see Figure 2).

    Later, non-metals were added, allowing analysts to determine the distribution of the API and some excipients. The most common elements measured are Mg, Cl, Na, K, I, Br, and Ca. Since many active pharmaceutical ingredients (APIs) contain Cl or Br, this makes following their distribution simple. Lab-based units have also been used to determine carbon distribution within a dosage form.

    I also mentioned 2-D NMR because of its importance in recent history. Several years ago, a number of people were killed by deliberately adulterated heparin. The mediate problem was a shortage of porcine intestines in China, so exporters bulked up their supply of heparin with over-sulfated chondroitin—as much as 50%—taken orally for arthritis pain and joint healing. The chemical is safe and benign, but taken intravenously, it is toxic. Sadly, wet compendial methods cannot distinguish between the two moieties. A fact the suppliers were aware of. So, there was a conference held by the USP to determine the best method of analysis for heparin.

    After all the presentations, the consensus was that 2-D NMR was the way to go. At that time, the available instruments were liquid helium cooled with levels maintained by liquid nitrogen and cost many thousands of dollars a day to maintain. Several years after that suggestion, I discovered an interesting unit built by Magritek named Spinsolve. It is a bench-top, room temperature unit, capable of measuring 1H and 19F nuclei, can perform 1-D and 2-D experiments, has a compact, benchtop size and weight, needs no sample spinning, thus, no compressed gas, and most importantly from a maintenance and cost factor, no cryogens are needed for operation. This unit should prevent future outbreaks of patient illness/death from adulterated materials, and is quite useful for API synthesis and control.

    In future columns, I will address some of the other technologies transforming the industry, speeding up and improving the way we analyze products, intermediates, and raw materials.


    Emil W. Ciurczak
    DoraMaxx Consulting

    Emil W. Ciurczak has worked in the pharmaceutical industry since 1970 for companies that include Ciba-Geigy, Sandoz, Berlex, Merck, and Purdue Pharma, where he specialized in performing method development on most types of analytical equipment. In 1983, he introduced NIR spectroscopy to pharmaceutical applications, and is generally credited as one of the first to use process analytical technologies (PAT) in drug manufacturing and development.
    Related Searches
    • merck
    • Dosage
    • it
    • API
    Suggested For You
    Trust, but Verify Trust, but Verify
    Drug Product Safety and Security Drug Product Safety and Security
    Too Much of a Good Thing? Too Much of a Good Thing?
    A Potential “Marriage” A Potential “Marriage”
    The Pandemic’s Become an Insurmountable Opportunity The Pandemic’s Become an Insurmountable Opportunity
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Current Trends in Analytical Testing Current Trends in Analytical Testing
    Analytical Equipment Technology for the 21st Century Analytical Equipment Technology for the 21st Century
    Formulating Candidates  with Bioavailability Issues Formulating Candidates with Bioavailability Issues
    Domain, Pfizer in bioSensAll Alliance   Domain, Pfizer in bioSensAll Alliance
    Quality Risk Management Quality Risk Management
    Reality and Un-Reality:  Continuous Processing in Pharmaceutical Manufacturing Reality and Un-Reality: Continuous Processing in Pharmaceutical Manufacturing
    Pfizer CentreOne Expands Service Portfolio Pfizer CentreOne Expands Service Portfolio
    Modeling & Simulation for  Drug Development & Formulation Modeling & Simulation for Drug Development & Formulation
    Implementing Continuous Manufacturing for Solid-Dosage Drugs Implementing Continuous Manufacturing for Solid-Dosage Drugs

    Related Columns

    • Trust, but Verify

      Trust, but Verify

      Or, R.I.P, CoA.
      Emil W. Ciurczak, DoraMaxx Consulting 09.09.21

    • Analytical Services | Supply Chain
      Drug Product Safety and Security

      Drug Product Safety and Security

      Is it even possible in an elongated supply chain?
      Emil Ciurczak, President, Doramaxx Consulting 07.16.21

    • Analytical Services
      Too Much of a Good Thing?

      Too Much of a Good Thing?

      Watch out for that pendulum!
      Emil W. Ciurczak, DoraMaxx Consulting 05.05.21


    • A Potential “Marriage”

      A Potential “Marriage”

      Initiator companies and generics/CMOs working together.
      Emil W. Ciurczak, DoraMaxx Consulting 11.17.20

    • The Pandemic’s Become an Insurmountable Opportunity

      The Pandemic’s Become an Insurmountable Opportunity

      Every Cloud has a Silver Lining(?)
      Emil W. Ciurczak, Contributing Editor 10.14.20

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login